Alicia Grande - 08 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Reporting relationship: VP, Treasurer and CFO
Issuer ticker: CPRX
Reported as of: 08 Dec 2023
Net transaction value: -$1,283,780
SEC form: 4
Accepted by SEC: 12 Dec 2023, 17:00:41 UTC
Prior SEC filing: 30 Mar 2023
Next SEC filing: 29 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Alicia Grande

Key filing fact

Alicia Grande filed Form 4 for CATALYST PHARMACEUTICALS, INC. (CPRX) on 12 Dec 2023.

Key facts

This page summarizes Alicia Grande's Form 4 filing for CATALYST PHARMACEUTICALS, INC. (CPRX).
8 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Dec 2023, 17:00.

Change

Previous filing in this sequence was filed on 30 Mar 2023.
Current net transaction value: -$1,283,780.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CPRX transaction

Common stock, par value $0.001 per share

Options Exercise

Transaction value: $45,200
Shares: +40,000
Change %: +79%
Price: $1.13^*
Shares after: 90,557
Date: 08 Dec 2023
Ownership: Direct

CPRX transaction

Common Stock, par value $0.001 per share

Sale

Transaction value: $285,000
Shares: -20,000
Change %: -22%
Price: $14.25
Shares after: 70,557
Date: 08 Dec 2023
Ownership: Direct
Footnotes: F1

CPRX transaction

Common Stock, par value $0.001 per share

Sale

Transaction value: $286,000
Shares: -20,000
Change %: -28%
Price: $14.30
Shares after: 50,557
Date: 08 Dec 2023
Ownership: Direct
Footnotes: F1

CPRX transaction

Common Stock, par value $0.001 per share

Options Exercise

Transaction value: $67,800
Shares: +60,000
Change %: +119%
Price: $1.13^*
Shares after: 110,557
Date: 11 Dec 2023
Ownership: Direct

CPRX transaction

Common Stock, par value $0.001 per share

Sale

Transaction value: $412,200
Shares: -30,000
Change %: -27%
Price: $13.74
Shares after: 80,557
Date: 11 Dec 2023
Ownership: Direct
Footnotes: F1, F2

CPRX transaction

Common Stock, par value $0.001 per share

Sale

Transaction value: $413,580
Shares: -30,000
Change %: -37%
Price: $13.79
Shares after: 50,557
Date: 11 Dec 2023
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CPRX transaction Derivative

Options to purchase common stock

Options Exercise

Transaction value: $0
Shares: -40,000
Change %: -3.1%
Price: $0.000000
Shares after: 1,255,834
Date: 08 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $1.13
Footnotes: F4

CPRX transaction Derivative

Options to purchase common stock

Options Exercise

Transaction value: $0
Shares: -60,000
Change %: -4.8%
Price: $0.000000
Shares after: 1,195,834
Date: 11 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $1.13
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Ms. Grande sold the shares on the open market, for personal reasons, and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a a result of any disagreement with the Company.

Footnote F2

Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.74 to $13.745 per share.

Footnote F3

Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.78 to $13.79 per share.

Footnote F4

Options vested in three annual tranches beginning on January 3, 2018.